METTL3 and osteosarcoma: METTL3 is perceived as an essential performer of m6A modifications in osteosarcoma (OS), bladder cancer (BCa), and cutaneous squamous cell carcinoma (cSCC), mediating the stemness properties of CSCs and tumor progression.94, 95, 96, 97